Pfizer Inc. Lipitor Subsidy May Affect Ranbaxy Laboratories, Deutsche Says

Bloomberg -- Pfizer Inc. (PFE)’s offer to subsidize its best-selling Lipitor drug in the U.S. may damp demand for copies of the cholesterol pill that Ranbaxy Laboratories Ltd. (RBXY) plans to sell later this year, Deutsche Bank AG said.